Moderna to Present at Upcoming Investor Conferences in February and March 2021

Rhea-AI Summary

Moderna (Nasdaq: MRNA) announced its participation in three upcoming virtual investor conferences. The events include the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021, at 1:00 p.m. ET, the Cowen & Co. 41st Annual Health Care Conference on March 1, 2021, at 8:00 a.m. ET, and the Barclays Global Healthcare Conference on March 11, 2021, at 10:20 a.m. ET. Live webcasts will be available on Moderna's investor website and archived for 30 days post-event. Moderna has significantly advanced in mRNA technology, delivering vaccines and therapeutics for various diseases, including COVID-19.

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following upcoming virtual investor conferences:

• SVB Leerink 10^th Annual Global Healthcare Conference on Thursday, February 25, 2021 at 1:00 p.m. ET.
• Cowen & Co. 41^st Annual Health Care Conference on Monday, March 1, 2021 at 8:00 a.m. ET (panel presentation).
• Barclays Global Healthcare Conference on Thursday, March 11, 2021 at 10:20 a.m. ET.

A live webcast of each presentation will be available under “Events and Presentations” in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna’s website for 30 days following the presentation.

About Moderna

In 10 years since its inception, Moderna has transformed from a science research-stage company advancing programs in the promising-but-still-unproven field of messenger RNA (mRNA), to an enterprise with its first medicine having treated millions of people, a diverse clinical portfolio of vaccines and therapeutics across six modalities, a broad intellectual property portfolio in areas including mRNA and lipid nanoparticle formulation, and an integrated manufacturing plant that allows for both clinical and commercial production at scale and at unprecedented speed. Moderna maintains alliances with a broad range of domestic and overseas government and commercial collaborators, which has allowed for the pursuit of both groundbreaking science and rapid scaling of manufacturing. Most recently, Moderna’s capabilities have come together to allow the authorized use of one of the earliest and most-effective vaccines against the COVID-19 pandemic.

Moderna’s mRNA platform builds on continuous advances in basic and applied mRNA science, delivery technology and manufacturing, and has allowed the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases and auto-immune diseases. Today, 24 development programs are underway across these therapeutic areas, with 13 programs having entered the clinic. Moderna has been named a top biopharmaceutical employer by Science for the past six years. To learn more, visit www.modernatx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210218005042/en/

FAQ

What conferences is Moderna (MRNA) participating in February and March 2021?

Moderna is participating in the SVB Leerink 10th Annual Global Healthcare Conference on February 25, 2021, the Cowen & Co. 41st Annual Health Care Conference on March 1, 2021, and the Barclays Global Healthcare Conference on March 11, 2021.

How can I watch Moderna's (MRNA) conference presentations?

You can watch Moderna's conference presentations via live webcasts available on the Investors section of their website, and replays will be archived for 30 days after each event.

What is the significance of Moderna's (MRNA) mRNA technology?

Moderna's mRNA technology has enabled the development of therapeutics and vaccines for various diseases, including one of the first effective vaccines against COVID-19.

When is the SVB Leerink Global Healthcare Conference featuring Moderna (MRNA)?

The SVB Leerink Global Healthcare Conference featuring Moderna is scheduled for February 25, 2021, at 1:00 p.m. ET.

Will Moderna (MRNA) present at the Cowen & Co. Health Care Conference?

Yes, Moderna will present at the Cowen & Co. 41st Annual Health Care Conference on March 1, 2021, at 8:00 a.m. ET.